Stockscreener 앱 받기
125.10
4.91%
5.86
시간 외 거래:
126.25
1.15
+0.92%
Jazz Pharmaceuticals Plc 주식(JAZZ)의 최신 뉴스
B.C. biotech Zymeworks gets FDA approval for new cancer drug - Business in Vancouver
FDA approves biliary tract cancer treatment from Jazz - BioWorld Online
Rare milestone for Canadian biotech as Zymeworks-developed drug gets FDA approval - The Globe and Mail
JAZZ Secures FDA Approval For Ziihera In Biliary Tract Cancer - Barchart
JAZZ Secures FDA Approval for Ziihera in Biliary Tract Cancer - Yahoo Finance
U.S. STOCKS Jazz Pharmaceuticals, SPAR, Alphabet - XM
Pacer Advisors Inc. Buys 278,465 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Thompson Siegel & Walmsley LLC Increases Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
FDA Greenlights Jazz Pharma's Cancer Drug, A Milestone For Zymework - Benzinga
John G Ullman & Associates Inc. Sells 11,400 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Pharmaceuticals stock trades at discount amid diversification efforts By Investing.com - Investing.com UK
Jazz stock Zymeworks stock gain on FDA nod (JAZZ:NASDAQ) - Seeking Alpha
Zymeworks' Ziihera Wins FDA Approval: First Dual HER2 Cancer Drug Shows 52% Response Rate | ZYME Stock News - StockTitan
JAZZ (Jazz Pharmaceuticals) COGS-to-Revenue : 0.11 (As of Sep. 2024) - GuruFocus.com
JAZZ (Jazz Pharmaceuticals) EPS without NRI : $19.61 (TTM As of Sep. 2024) - GuruFocus.com
Jazz Pharmaceuticals receives FDA approval for biliary tract cancer treatment - Reuters
Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC) - JAZZ's Investor Relations
Jazz Pharmaceuticals to Participate in Citi's 2024 Global Healthcare Conference - PR Newswire
Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock? - Yahoo Finance
Silver Ring Value Partners: Jazz Pharmaceuticals (JAZZ) Is a “High Uncertainty With Low Risk” Investment - Insider Monkey
Jazz Pharmaceuticals: High Uncertainty, Low Risk (undefined:JAZZ) - Seeking Alpha
Jazz Pharmaceuticals shares target raised on patient base growth By Investing.com - Investing.com UK
Is Jazz Pharmaceuticals plc (JAZZ) the Best Immunotherapy Stock to Buy Now? - Insider Monkey
Jazz Pharmaceuticals (NASDAQ:JAZZ) Given New $162.00 Price Target at Robert W. Baird - MarketBeat
Victory Capital Management Inc. Has $28.22 Million Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Tops Q3 Earnings & Sales Estimates, Raises '24 EPS View - MSN
Los Angeles Capital Management LLC Makes New Investment in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Pharmaceuticals Plc: Its Efforts Towards Zepzelca Frontline Therapy Expansion & Other Major Drivers - Smartkarma
KBC Group NV Has $25.44 Million Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Principal Financial Group Inc. Trims Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Idiopathic Hypersomnia Treatment Market will experience - openPR
Is the Options Market Predicting a Spike in Jazz (JAZZ) Stock? - Yahoo Finance
We Think Jazz Pharmaceuticals' (NASDAQ:JAZZ) Profit Is Only A Baseline For What They Can Achieve - Simply Wall St
Jazz Pharmaceuticals' (NASDAQ:JAZZ) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance
Jazz Pharmaceuticals' EVP Neena Patil sells $456,617 in shares By Investing.com - Investing.com Australia
Brokerages Set Jazz Pharmaceuticals plc (NASDAQ:JAZZ) PT at $175.00 - MarketBeat
Jazz Pharmaceuticals' EVP Neena Patil sells $456,617 in shares - Investing.com
Jazz (JAZZ) Upgraded to Buy: Here's Why - Yahoo Finance
JAZZ or CTLT: Which Is the Better Value Stock Right Now? - Yahoo Finance
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Purchased by Kovack Advisors Inc. - MarketBeat
Wall Street Analysts See a 37.65% Upside in Jazz (JAZZ): Can the Stock Really Move This High? - Yahoo Finance
Is Collegium Pharmaceutical (COLL) a Great Value Stock Right Now? - Yahoo Finance
American Assets Inc. Invests $557,000 in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Jazz Pharmaceuticals plc Updates Earnings Guidance for the Full Year 2024 - Marketscreener.com
Jazz (JAZZ) Reliance on International Sales: What Investors Need to Know - Yahoo Finance
28,693 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Bought by CWA Asset Management Group LLC - MarketBeat
Amalgamated Bank Sells 9,681 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Philip James Wealth Mangement LLC Makes New Investment in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q3 2024 Earnings Call Transcript - Insider Monkey
Van ECK Associates Corp Increases Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Pharmaceuticals plc (JAZZ) Quarterly 10-Q Report - Quartzy
Jazz Pharma revenues rise 9% in third quarter | Pharmaceutical | The Pharmaletter - The Pharma Letter
Jazz Pharmaceuticals' (JAZZ) "Buy" Rating Reaffirmed at Needham & Company LLC - MarketBeat
Robeco Institutional Asset Management B.V. Sells 19,161 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Pharmaceuticals PLC (JAZZ) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Jazz Pharmaceuticals Reports Strong Q3 2024 Growth - TipRanks
Jazz Hits Record Q3 Revenue with Strong Growth in Sleep Portfolio - Sleep Review
Compared to Estimates, Jazz (JAZZ) Q3 Earnings: A Look at Key Metrics - Yahoo Finance
Jazz Pharmaceuticals Reports Strong Q3: Will Debt Weigh On Its Future Growth? - Benzinga
Jazz Pharmaceuticals (JAZZ) Q3 Earnings and Revenues Top Estimates - Yahoo Canada Finance
Jazz: Q3 Earnings Snapshot - San Antonio Express-News
0.93%
3.55%
자본화:
|
볼륨(24시간):